Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Probably from the guidance in this PR.
OTC DISCLOSURE & NEWS SERVICE
Wuhan General Group Inc Cancels 5,000,000 Common Shares
Press Release | 11/22/2021
CAPE TOWN, SA / ACCESSWIRE / November 22, 2021 / WUHAN GENERAL GROUP, INC. (OTC PINK:WUHN) ("WGG'' or the "Company"), a bioceutical company focused on alternative plant-based cannabinoids and psilocybin medical research is pleased to share the following update:
LogoDescription automatically generated
M2Bio Sciences is pleased to announce that 5,000,000 common shares held by the previous CEO have been cancelled. The company has reduced its share capital by 9%. The total number of issued common shares is now 50,999,662. (previously 55,999,662).
M2Bio Sciences CEO and Founder Jeff Robinson explains "In our continued efforts to clean up the capital structure of the company and in preparation for a nifty and rewarding 2022, this is merely baby step number one. We are looking forward to executing and delivering by leaps and bounds in the near future."
About Wuhan General Group, Inc./ M2Bio Sciences, Inc
Wuhan General Group, Inc. (DBA M2bio Sciences), through its wholly-owned subsidiary MJ MedTech is a nutraceutical biotechnology company focused on alternative plant-based cannabinoids and psilocybin medical research that develops and commercializes a range of CBD and mushrooms-based products under Dr. AnnaRx™, Medspresso™, and Liviana™ brands. In addition, our research and clinical trials with psilocybin are aimed at new therapies that will help patients who suffer from alcohol addiction, mental illness, and cardiovascular diseases. Our mission is to advance botanical-based medicine to the forefront by deploying best-practice science and medicine, clinical research, and emerging technologies. The Company is traded on the Over-the-Counter Bulletin Board of NASDAQ under the trading symbol "WUHN".
For further information:
Publicly traded company (OTC PINK:WUHN)
Website: www.m2bio.co
E-mail: info@m2bio.co
Follow us on Twitter: https://twitter.com/m2bio
Follow us on Facebook: http://www.facebook.com/m2bio
Follow us on Instagram: https://www.instagram.com/m2bio.sciences
Forward-Looking Statements:
Safe Harbour Statement - In addition to historical information, this press release may contain statements that constitute forward-looking statements within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Forward-looking statements contained in this press release include the intent, belief, or expectations of the Company and members of its management team with respect to the Company's future business operations and the assumptions upon which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance, and involve risks and uncertainties and that actual results may differ materially from those contemplated by such forward-looking statements. Factors that could cause these differences include, but are not limited to, failure to complete anticipated sales under negotiations, lack of revenue growth, client discontinuances, failure to realize improvements in performance, efficiency and profitability, and adverse developments with respect to litigation or increased litigation costs, the operation or performance of the Company's business units or the market price of its common stock. Additional factors that could cause actual results to differ materially from those contemplated within this press release can also be found on the Company's website. The Company disclaims any responsibility to update any forward-looking statements.
SOURCE: Wuhan General Group, Inc./ M2Bio Sciences, Inc
View source version on accesswire.com:
https://www.accesswire.com/674049/Wuhan-General-Group-Inc-Cancels-5000000-Common-Shares
Starting to smell like dilution in here.
Why did MRGE change to OTC-Expert-Market again?
As of 11/30/2021 Market change from Pink Limited to Expert Market. https://www.otcmarkets.com/stock/MRGE/security
Absolutely!
Very informative video, thank you. Would you kindly increase the volume of your microphone though, I couldn't hear you well unless I cranked up my speaker volume.
Slight increase in short seller interest.
SHORT INTEREST
DATE SHORT INTEREST % CHANGE AVG. DAILY SHARE VOL DAYS TO COVER SPLIT NEW ISSUE
11/15/2021 148,375 29.81 235,784 1 No No
10/29/2021 114,300 15.32 252,746 1 No No
10/15/2021 99,117 -2.33 181,361 1 No No
09/30/2021 101,479 -7.14 72,177 1.41 No No
09/15/2021 109,286 10.63 54,185 2.02 No No
08/31/2021 98,781 -0.57 107,071 1 No No
08/13/2021 99,350 0.76 48,032 2.07 No No
07/30/2021 98,605 0.10 67,791 1.45 No No
07/15/2021 98,505 -4.46 87,160 1.13 No No
06/30/2021 103,104 1.39 162,472 1 No No
CEO_Thom-Brian-David converting shares @$0.50 & sold @$0.76
https://www.otcmarkets.com/filing/conv_pdf?id=15381865&guid=GEywkHWfXB7fJth
Does anyone have an extra $122,432 to buy up today's offers?
0.75 124032 $93,024
0.75 10000 $7,500
0.76 22400 $17,024
0.77 5000 $3,850
0.795 1300 $1,034
TOTAL$ $122,432
OTTV can start reporting via OTCmarkets.com; there is no reason deregistering from SEC is the last straw. Other companies have done this.
IMO it is worth the speculation dollars.
easy to buy, hard to sell.
which broker do you use? do you get free commissions?
News $UEEC Ownership disclosures, Insider transactions. Annual statement of changes in beneficial ownership of securities as of 11/05/2021 01:01:20 PM EST. https://bit.ly/3CZlKTQ
Is doubling the authorized shares similar to reverse-split?
News! INSTANTGMP™ Announces new client: United Health Products. $UEEC enhances its operations with InstantGMP™ PRO All- In-One Manufacturing software and Learning Management System. https://yhoo.it/3mgTQgl
at least double from here.
I guess we don't need a PR, it's already been said in the messages below.
This is not how a healthy bull trades.
No shortage of shares available since the SEC S-3 form became effective.
Did you happen to keep any long shares stuffed away?
I have no idea as to why this trading activity occurred today. I just noticed it since I keep an eye on this stock daily.
I love to sell this action!
Are we expecting something by this upcoming Monday?
Quoting from the 8-K April 13, 2021.
Item 8.01. Other Events
The company is working on documents to bring up to date all SEC filings.
The company is also working on full employment contracts for the interim CEO to make this a permanent position and is further agreeing a contract with the new CFO. The market will be updated of this in the coming weeks.
The new Nevada corporation is a new entity unrelated to any events surrounding the previous bankruptcy.
The board will be announcing a new pharmaceutical asset once details have been finalized.
We will be applying to Finra once all SEC filings are up to date to have the “Q” status removed, we expect this corporate action to be initiated within 30 days.
https://www.sec.gov/Archives/edgar/data/0001208261/000149315221008603/form8-k.htm
I searched the 10-K filing and don't see a R/S mentioned. Did the company confirm a R/S or are you speculating that it might happen?
Nasdaq approved LWLG uplisting. SEC CERT filed today.
https://www.otcmarkets.com/filing/pdf?id=15200749&guid=I_l9kePL-zC3D3h
Talk about leaving it until last minute...
What is a 10-12G play?
Not unless someone plans to buy $129,222 of stock at $1.10
Anyone suggested REVERSE SPLIT?
What do you mean by "bankrupted?"
Did you take profits along the way?
We have had three liquid trading days within the past 6 months in the $0.03-0.04 range.
Insiders be singing 'I_get_it_one_piece_at_a_time_and_it_didn't_cost_me_a_dime!'
Was it posted on June 10?
June-10 sharedholder update published to Company website.
I think the Company delayed publishing this shareholder update on their website until yesterday, June-15.
http://www.encountercare.com/updates/update.aspx
Do you have the link/URL for this source?
Since when do shareholders dispute higher prices?!?
Anyone have more ammo?
Yes here is the proof the $1.45 trade occurred.
Date/Time Price Shares Exch/Mkt
06/09/2021 11:24:16 EDT 1.15 3200 OTCBB
06/09/2021 11:24:02 EDT 1.15 100 OTCBB
06/09/2021 11:21:37 EDT 1.15 750 OTCBB
06/09/2021 11:21:11 EDT 1.124 250 OTCBB
06/09/2021 11:19:36 EDT 1.1499 200 OTCBB
06/09/2021 11:19:36 EDT 1.15 200 OTCBB
06/09/2021 11:19:30 EDT 1.1499 400 OTCBB
06/09/2021 11:19:30 EDT 1.15 400 OTCBB
06/09/2021 11:19:24 EDT 1.1499 200 OTCBB
06/09/2021 11:19:24 EDT 1.15 200 OTCBB
06/09/2021 11:19:19 EDT 1.135 1000 OTCBB
06/09/2021 11:19:18 EDT 1.1499 200 OTCBB
06/09/2021 11:19:18 EDT 1.15 200 OTCBB
06/09/2021 11:16:19 EDT 1.45 3300 OTCBB
06/09/2021 11:16:19 EDT 1.20 500 OTCBB
06/09/2021 11:16:10 EDT 1.18 100 OTCBB
06/09/2021 11:16:04 EDT 1.12 500 OTCBB
06/09/2021 11:15:52 EDT 1.11 100 OTCBB
06/09/2021 11:13:24 EDT 1.08 3491 OTCBB
06/09/2021 11:11:07 EDT 1.10 500 OTCBB
06/09/2021 11:10:54 EDT 1.10 1009 OTCBB
06/09/2021 11:10:43 EDT 1.10 800 OTCBB
06/09/2021 11:10:42 EDT 1.10 200 OTCBB
06/09/2021 11:04:05 EDT 1.11 500 OTCBB
06/09/2021 10:56:20 EDT 1.11 7500 OTCBB
06/09/2021 10:56:12 EDT 1.115 875 OTCBB
06/09/2021 10:49:07 EDT 1.12 500 OTCBB
06/09/2021 10:44:19 EDT 1.13 500 OTCBB
06/09/2021 10:41:11 EDT 1.11 2500 OTCBB
06/09/2021 10:24:48 EDT 1.13 900 OTCBB
Who is this apex that you are referring to? Is that a market maker?